Periodontitis clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18-80
The experiment outlined in this proposal is designed to test the hypothesis that herpesvirus suppression by the systemic anti-herpesvirus valacyclovir (Valtrex) can significantly help to arrest the progressive course of severe marginal periodontitis in adult patients. A prospective, randomized, placebo-controlled, double-blind, clinical trial is employed to test this hypothesis.
Our lead scientists for Periodontitis research studies include Mike Sabeti, DDS.